Search

Germany: Animal Nutrition Evonik to Focus on DL-Methionine Production at its Global Hubs

Editor: Ahlam Rais

Evonik is all set to concentrate on its Metamino (DL-methionine) production at three of its world-scale hubs in Europe, Americas and Asia. With this move, the firm aims to strengthen its competitiveness in the market in terms of cost.

Related Companies

Evonik will invest about 29 million dollars into upgrading its world-scale plant for methionine intermediates in Wesseling, Germany.
Evonik will invest about 29 million dollars into upgrading its world-scale plant for methionine intermediates in Wesseling, Germany.
(Source: Deposit Photos)

Essen/Germany – Evonik is to cluster its Metamino (DL-methionine) production at three international hubs (Americas, Europe, and Asia) to maximise economies of scale and utilise robust processes.

Evonik is a leading global manufacturer of DL-methionine, an essential amino acid which is used in modern feed formulation therefore enabling the company to play a pivotal role in addressing sustainable animal protein supply, food safety and animal welfare.

All three of Evonik’s world-scale Metamino plants operate along cost leading, best-in-class technology lines, and offer opportunities for further expansion. They are also ready for cost efficient modular debottlenecking in the future. Evonik believes it is now perfectly positioned for future growth at an improved competitive cost position.

Following this strategy, Evonik is to close the smallest of its Metamino plants with a capacity of 65,000 tonnes per year, located in Wesseling, Germany, by the end of the first quarter, 2021. In addition, Evonik will invest about 29 million dollars into upgrading its world-scale plant for methionine intermediates in Wesseling to safeguard long-term supply to the Antwerp site and to strengthen its European Metamino-Verbund.

PROCESS Insights 2020-05
Challenges for EPC Contractors

With an influx of largescale petrochemical construction projects, EPC Contractors will have to be confronted with challenges such as finding enough capacity and quality of construction manpower, delayed permits etc. which require an EPC strategy to stay competitive in this ever-growing market.

This 12-page Process Insight will discuss the current changes in the EPC business and the impact of these changes on EPC projects. Besides the effect of the Coronavirus as well as the current oil price crash on the contracting industry will also be analyzed and an outlook for the industry will be given.

This will lead to a better cost position – through improved utilisation of capacity – with economies of scale and an enhanced ability to adapt to any market condition.

Dr. Emmanuel Auer, head of Animal Nutrition business line at Evonik, said: “The methionine business is important for Evonik, now and in the future. We will adapt to market challenges and prepare our asset set-up for highest efficiency and further optimised cost structures. We have engaged in continuous efficiency measures and programmes over the past few years. As part of structural asset optimisation, the time felt right to close the smallest methionine asset.”

In 2014, Evonik opened its methionine production facility in Singapore. In 2019 the company doubled the nameplate capacity at the site. Today Singapore is the largest DL-methionine production complex in the world with a nameplate capacity of 300,000 tonnes per year Metamino; a new industry standard for efficient, safe and sustainable operation.

Alongside Singapore, Evonik operates world-scale facilities in Mobile, Alabama, USA; and in Antwerp, Belgium. Evonik has been producing Metamino in Wesseling since 1967.

(ID:46934896)